News

Meanwhile, CVS/Caremark confirms the health benefits of better adherence

Companies are positioning themselves as approved high-volume compounders

Non-governmental certification agencies are better than nothing, but are they good enough?

Knipper claims No. 1 position as national provider of sample distribution for pharma

Plaintiffs will seek additional funds from medical providers and pain clinics that prescribed the tainted steroids

An inaugural meeting was held in November; meanwhile Chinese government activities to shut down counterfeiting expand

Multichannel marketing is high in attention, but low on execution

Both Revitas and Model N bring out enhanced script-validation modules to ensure rebate accuracy

Companies will form a 50-50 joint venture to share generics sourcing

While the US and China lead in volume of citations, Singapore, Italy, Japan and Israel are coming on

Dublin hub will handle clinical trial materials (CTMs) of all temperature ranges

54 companies share in a $60-million tax credit fund for FY2014

Consultants rank firms by financials, supply-chain performance and reputation

HDMA's 2013-14 Factbook updates member financial, operational performance

Contract packager addresses growing clinical-products business

Commercial launch planning should begin early in Phase II, says the company

Will 'white bagging' and specialty-pharmacy business practices change distribution dynamics?

Intelliject's Auvi-Q auto-injector wins an award from ISMP and points to a future of more self-administered injections

New KoolTemp GTS parcels have higher performance and lower cost and weight

Walgreens' Pharma Dynamics subsidiary will be merged into CareMetX

Pharma track-and-trace arrives, but will take years to be fully implemented; drug compounding also gets a new regulatory framework

Growth includes 1-4% CAGR in U.S., 0-3% in Europe and 14-17% in China. US specialties have a twist

Finance, marketing and other nontraditional users find value in the company's sales and inventory data

Nonprofit will continue industry collaborations on shared resources for drug discovery and development

HDMA members gather to discuss track-and-trace technicalities, even while Congress almost--again--passes the Drug Quality and Security Act

New "emergent biopharma" service combine compliance with pricing, market access

Will the Microsoft Surface tablet displace Apple's iPad popularity among pharma sales forces?